LOGIN  |  REGISTER
Terns Pharmaceuticals

Assure (NASDAQ: IONM) Stock Quote

Last Trade: US$0.05
Volume: 0
5-Day Change: -98.55%
YTD Change: -82.35%
Market Cap: US$141K

Latest News From Assure

DENVER, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (“Assure” or the “Company”) (OTC: IONM), today announced that it has extended the expiration date of its exchange offer (the “Offer”) relating to the Company’s 9% Convertible Debentures due 2023 and 2024 (the “Assure Convertible Debentures”). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on September 6,... Read More
DENVER, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (“Assure” or the “Company”) (OTC: IONM), today announced that it has extended the expiration date of its exchange offer (the “Offer”) relating to the Company’s 9% Convertible Debentures due 2023 and 2024 (the “Assure Convertible Debentures”). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on August 23,... Read More
DENVER, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (“Assure” or the “Company”) (OTC: IONM), today announced that it has extended the expiration date of its exchange offer (the “Offer”) relating to the Company’s 9% Convertible Debentures due 2023 and 2024 (the “Assure Convertible Debentures”). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on August 16,... Read More
DENVER, July 29, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (“Assure” or the “Company”) (NASDAQ: IONM), today announced that it has extended the expiration date of its exchange offer (the “Offer”) relating to the Company’s 9% Convertible Debentures due 2023 and 2024 (the “Assure Convertible Debentures”). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on August 2,... Read More
DENVER, July 22, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (“Assure” or the “Company”) (NASDAQ: IONM), today announced that it has extended the expiration date of its exchange offer (the “Offer”) relating to the Company’s 9% Convertible Debentures due 2023 and 2024 (the “Assure Convertible Debentures”). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on July 26,... Read More
DENVER, July 03, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring ( “IONM ”) and remote neurology services, today announced that it will effect a reverse stock split (the “ Reverse Stock Split ”) of its shares of common stock, $0.001 par value, at a ratio of 18 (old) for 1 (new) that will become effective on July 9, 2024 at 12:01 a.m.... Read More
DENVER, May 28, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today announced that it received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that as a result of the delinquency in the timely filing of the Company’s quarterly report on Form 10-Q for the period... Read More
DENVER, May 17, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that management has rescheduled the joint corporate update call with Danam for Wednesday, May 22, 2024 at 4:00 PM Eastern Time. Conference Call Information Date: Wednesday, May 22, 2024 Time: 4:00 PM Eastern Time Toll... Read More
DENVER, May 16, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today it received a written notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that it has granted the Company an extension to regain compliance with the... Read More
DENVER, May 16, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that at its adjourned Special Shareholder Meeting held on May 14, 2024, shareholders approved the proposal to amend the Company’s Articles of Incorporation, to increase the number of authorized shares of common stock of... Read More
DENVER, May 15, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that the joint corporate update call with Danam scheduled for Thursday, May 16, 2024 at 4 p.m. Eastern Time has been postponed. The Company plans to reschedule the conference call at a later date. About Assure Holdings... Read More
DENVER, May 13, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that management will host a joint corporate update call with Danam on Thursday, May 16, 2024 at 4:00 PM Eastern Time to provide a corporate update. Conference Call Information Date: Thursday, May 16, 2024 Time: 4:00 PM... Read More
Of the Votes Received to Date, More than 95% Are Voting in Favor of the Increase More Votes Are Needed to Reach 50% of the Outstanding Shares Required for the Increase Every Vote Is Important to Avoid Delay in Completion of the Increase DENVER, May 06, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services,... Read More
DENVER, March 28, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it closed the sale of certain assets of its IONM business to MPOWERHealth on March 26, 2024. The sale includes proceeds of up to $4.5 million, of which $2.32 million was paid in cash at the initial closing and up... Read More
DENVER, March 11, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it has entered into an agreement to sell certain assets of its IONM business to MPOWERHealth for up to $4.5 million, of which $2.5 million will be paid in cash at the initial closing and up to an additional $2.0... Read More
DENVER, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (“Assure”) (Nasdaq: IONM) today announced that it has entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with Danam Health, Inc. (“Danam”) under which Danam will merge with a newly-formed, wholly-owned subsidiary of Assure in a stock-for-stock transaction (the “Merger”) in which Danam will survive as a wholly-owned subsidiary of... Read More
DENVER, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today announced that on November 21, 2023 it received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that as a result of the delinquency in the timely filing of the Company’s quarterly report on... Read More
DENVER, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today announced that it received notice from the Staff of the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market, LLC (“Nasdaq”) that the Staff has determined to grant the Company an extension of time to... Read More
DENVER, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM ), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today announced that its Board of Directors has initiated a process to explore strategic alternatives. In consultation with financial and legal advisors, the comprehensive strategic review process will begin immediately and... Read More
DENVER, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today announced that management will host 1x1 meetings in person at the H.C. Wainwright 25 th Annual Global Investment Conference. Event: H.C. Wainwright 25 th Annual Global Investment Conference Date: September 11-13, 2023... Read More
DENVER, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today reported financial results for the second quarter and year-to-date periods ended June 30, 2023. Key Financial Highlights (in thousands of USD) 2Q 2023 2Q 2022 YTD through Q2 2023 YTD through Q2 2022 Gross Revenue $ 4,006 $... Read More
DENVER, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today announced that it has rescheduled its second quarter 2023 earnings release and conference call to 4:30 p.m. Eastern Time on August 15, 2023. The call was previously scheduled for 5:30 p.m. Eastern Time on August 14, 2023.... Read More
DENVER, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, will hold a conference call on Monday, August 14, 2023 at 5:30 p.m. Eastern Time to discuss its financial results for the second quarter ended June 30, 2023. The live webcast of the conference call and related presentation slides... Read More
DENVER, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today announced that it has acquired certain assets of Innovation Neuromonitoring, LLC (“Innovation”) for approximately $1.2 million in a cash and equity transaction. John Farlinger, Assure’s executive chairman and CEO,... Read More
DENVER, June 27, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today announced that it has signed a Diagnostics Services Agreement with Neurovative Diagnostics, LLC (“Neurovative Diagnostics”), a global leader in the neurodiagnostic field. The agreement enables the Company to expand its... Read More
DENVER, June 26, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today announced that it has signed a Letter of Intent (“ LOI ”) to purchase certain assets of Innovation Neuromonitoring, LLC (“ Innovation ”) for approximately $1.2 million in a cash and equity transaction. Established in 2016,... Read More
DENVER, June 01, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, announced management will be presenting at upcoming conferences in June: Gravitas’ Los Angeles Summit at the Beverly Hills Hotel from Sunday, June 4th to Wednesday, June 7th, 2023, in Beverly Hills, California. Management will be... Read More
DENVER, May 16, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (NASDAQ: IONM) (“ Assure Holdings ” or the “ Company ”), a provider of intraoperative neuromonitoring and remote neurology services, today announced the closing of an underwritten public offering of 5,000,000 shares of its common stock (or prefunded warrants in lieu thereof) at an offering price to the public of $1.20 per share (or $1.199 per pre-funded warrant).... Read More
DENVER, May 12, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, will hold a conference call on Tuesday, May 16, 2023 at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2023. The live webcast of the conference call and related presentation slides... Read More
DENVER, May 12, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (NASDAQ: IONM) (“ Assure Holdings ” or the “ Company ”), a provider of intraoperative neuromonitoring and remote neurology services, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock (or pre-funded warrants in lieu thereof) at an offering price to the public of $1.20 per share (or $1.199 per pre-funded... Read More
DENVER, May 10, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today reported its preliminary financial results for the first quarter ended March 31, 2023. Key Financial Highlights (in thousands of USD) 1Q'23 1Q'22 Gross Revenue $ 4,790 $ 9,136 Accounts Receivable Reserve (1,238 ) (4,435 )... Read More
Expects $3.3 Million Federal Tax Refund for Employee Retention Credit (ERC) Multi-Million Dollar Reimbursement Lawsuit Set for Jury Trial in July DENVER, May 08, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today provided a corporate update related to its expectations for cash proceeds from... Read More
DENVER, May 05, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (Nasdaq: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today announced that it has expanded its operations and performed its first neuromonitoring case in the state of Montana. The first case was performed pursuant to a relationship established between Assure and a distinguished... Read More
DENVER, April 03, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today reported financial results for the full year ended December 31, 2022. Key Financial Metrics (in thousands of USD) FY 2022 FY 2021 Gross Revenue $28,854 $36,583 Accounts Receivable Reserve (17,878 ) (7,391 ) Revenue, net... Read More
DENVER, March 31, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, will hold a conference call on Monday, April 3, 2023 at 9:00 a.m. Eastern Time to discuss its financial results for the fourth quarter and year ended December 31, 2022. The live webcast of the conference call and related... Read More
DENVER, March 24, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that the company has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) that it has regained compliance with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2) and... Read More
DENVER, March 03, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring ( “IONM ”) and remote neurology services, today announced that it effected a reverse stock split (the “ Reverse Stock Split ”) of its shares of common stock, $0.001 par value, at a ratio of 20 (old) for 1 (new) that will become effective on March 4, 2023 at 12:01 a.m.... Read More
DENVER, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, is pleased to announce it will be presenting at the Gravitas 6 th Annual Growth Conference taking place at the Fairmont Pacific Rim Hotel on Thursday, March 2nd, 2023, in Vancouver, British Columbia. John A. Farlinger, Assure’s... Read More
DENVER, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, has been invited to present at the Third Annual Winter Wonderland – Best Ideas Virtual Investor conference, which is being held virtually on February 21st – 24th, 2023. John Price, Assure’s Chief Financial Officer, will be... Read More
DENVER, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today announced a cost reduction plan (the “ Plan ") intended to accelerate its path to EBITDA profitability and positive operating cash flow. The Plan is expected to reduce operating costs by more than $2.0 million on an... Read More
DENVER, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, is pleased to announce that on December 31, 2022, it completed the acquisition (the “ Acquisition ”) of substantially all of the assets of Neuroprotect Neuromonitoring, LLC, and certain of its affiliated entities (collectively, “... Read More
DENVER, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, announced today that it held its annual general meeting of shareholders on December 28, 2022 (the “ Meeting ”) and that all matters submitted to the shareholders of the Company for approval as set out in the Company’s definitive... Read More
Assertio

COPYRIGHT ©2023 HEALTH STOCKS HUB